Mycobacterium genavense infections: A retrospective multicenter study in France, 1996-2007

Medicine

Volumn 90, Issue 4, 2011, Pages 223-230

  Charles, Pierre ^a,b   Lortholary, Olivier ^a,c   Dechartres, Agnès ^d   Doustdar, Fahranoosh ^c   Viard, Jean Paul ^a   Lecuit, Marc ^a,c,d   Gutierrez, Maria Cristina ^c,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b FOCH HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BONE MARROW; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; FECES; FEMALE; FEVER; FRANCE; HEALTH CENTER; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INTESTINE BIOPSY; LYMPHADENOPATHY; MALE; MULTICENTER STUDY; MYCOBACTERIUM GENAVENSE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SPLENOMEGALY; SPUTUM; SURVIVAL RATE; WEIGHT REDUCTION;

ADULT; AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; COMORBIDITY; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 79959778338     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e318225ab89     Document Type: Article

References (37)

1. Albrecht H, Rusch-Gerdes S, Stellbrink HJ, Greten H, Jackle S. Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis. Clin Infect Dis. 1997;25:742-743.
2. Berman SM, Kim RC, Haghighat D, Mulligan ME, Fierer J, Wyle FC. Mycobacterium genavense infection presenting as a solitary brain mass in a patient with AIDS: case report and review. Clin Infect Dis. 1994;19:1152-1154. (Pubitemid 24380036)
3. Bessesen MT, Shlay J, Stone-Venohr B, Cohn DL, Reves RR. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 1993;7:1357-1361. (Pubitemid 23330307)
4. Bogdan C, Kern P, Richter E, Tannapfel A, Rusch-Gerdes S, Kirchner T, Solbach W. Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient whowas seronegative for human immunodeficiency virus. Clin Infect Dis. 1997;24:1245-1247. (Pubitemid 27249033)
5. Bosquee L, Bottger EC, De Beenhouwer H, Fonteyne PA, Hirschel B, Larsson L, Meyers WM, Palomino JC, Realini L, Rigouts L, et al. Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods. J Clin Microbiol. 1995;33:2670-2674.
6. Bottger EC, Hirschel B, Coyle MB. Mycobacterium genavense sp. nov. Int J Syst Bacteriol. 1993;43:841-843.
7. Bottger EC, Teske A, Kirschner P, Bost S, Chang HR, Beer V, Hirschel B. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet. 1992;340:76-80.
8. Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010;24:1549-1559.
9. Daum S, Moos V, Loddenkemper C, Schurmann C, Marker-Hermann E, Stein H, Zeitz M, Schneider T. EImmune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis. Z Rheumatol. 2008;67:277-278, 280-283.
10. de Lastours V, Guillemain R, Mainardi JL, Aubert A, Chevalier P, Lefort A, Podglajen I. Early diagnosis of disseminated Mycobacterium genavense infection. Emerg Infect Dis. 2008;14:346-347. (Pubitemid 351213698)
11. Fournier S, Pialoux G, Vincent V. Mycobacterium genavense and cutaneous disease in AIDS. Ann Intern Med. 1998;128:409. (Pubitemid 28103112)
12. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615-1627. (Pubitemid 39095778)
13. Gaynor CD, Clark RA, Koontz FP, Emler S, Hirschel B, Schlesinger LS. Disseminated Mycobacterium genavense infection in two patients with AIDS. Clin Infect Dis. 1994;18:455-457. (Pubitemid 24086325)
14. Griffith DE, Wallace RJ Jr. New developments in the treatment of nontuberculous mycobacterial (NTM) disease. Semin Respir Infect. 1996;11:301-310. (Pubitemid 26425466)
15. Hirschel B, Chang HR, Mach N, Piguet PF, Cox J, Piguet JD, Silva MT, Larsson L, Klatser PR, Thole JE, Rigouts L, Portaels F. Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:109-113. (Pubitemid 20221648)
16. Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis. 2004;4:557-565. (Pubitemid 39141797)
17. Kirschner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, Bange FC, Bottger EC. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol. 1993;31:2882-2889. (Pubitemid 23318373)
18. Krebs T, Zimmerli S, Bodmer T, Lammle B. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. J Intern Med. 2000;248:343-348.
19. Leautez S, Boutoille D, Bemer-Melchior P, Ponge T, Raffi F. Localized Mycobacterium genavense soft tissue infection in an immunodeficient HIV-negative patient. Eur J Clin Microbiol Infect Dis. 2000;19:51-52. (Pubitemid 30093383)
20. Liberek V, Soravia C, Ninet B, Hirschel B, Siegrist CA. Cervical lymphadenitis caused by Mycobacterium genavense in a healthy child. Pediatr Infect Dis J. 1996;15:269-270. (Pubitemid 26098482)
21. Lorenzen J, Meyer-Olson D, Haubitz M, Witte T, Bange F, Schmidt R, Stoll M. Infection with Mycobacterium genavense in a patient with systemic lupus erythematosus. Clin Rheumatol. 2009;28(Suppl 1): S39YS41.
22. Lu KJ, Grigg A, Leslie D, Finlay M, Sasadeusz J. Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation. Transpl Infect Dis. 2009;11:534-536.
23. Matsiota-Bernard P, Thierry D, De Truchis P, Saillour M, Paraire F, Guesdon JL, Nauciel C. Mycobacterium genavense infection in a patient with AIDS whowas successfully treated with clarithromycin. Clin Infect Dis. 1995;20:1565-1566.
24. Monill JM, Franquet T, Sambeat MA, Martinez-Noguera A, Villalba J. Mycobacterium genavense infection in AIDS: imaging findings in eight patients. Eur Radiol. 2001;11:193-196. (Pubitemid 32755435)
25. Nurmohamed S, Weenink A, Moeniralam H, Visser C, Bemelman F. Hyperammonemia in generalized Mycobacterium genavense infection after renal transplantation. Am J Transplant. 2007;7:722-723. (Pubitemid 46376462)
26. Pai S, Esen N, Pan X, Musser JM. Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). Arch Pathol Lab Med. 1997;121:859-864. (Pubitemid 27357581)
27. Pechere M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, Hein R, von Overbeck J, Clark RA, Tortoli E, et al. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med. 1995;155:400-404.
28. Realini L, De Ridder K, Hirschel B, Portaels F. Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense. Diagn Microbiol Infect Dis. 1999;34:45-50. (Pubitemid 29216936)
29. Realini L, Van Der Stuyft P, De Ridder K, Hirschel B, Portaels F. Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures. J Clin Microbiol. 1997;35:2791-2794. (Pubitemid 27452411)
30. Sanguinetti M, Posteraro B, Ardito F, Zanetti S, Cingolani A, Sechi L, De Luca A, Ortona L, Fadda G. Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol. 1998;36:1530-1533. (Pubitemid 28226024)
31. Sharifian A, Humphris J, Leong RW, Jones DB. Education and imaging. Gastrointestinal: Mycobacterium genavense enteritis in an immunosuppressed patient. J Gastroenterol Hepatol. 2009;24:1474.
32. Tartaglione T. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. Clin Ther. 1997;19:626-638. (Pubitemid 27425299)
33. Thomsen VO, Dragsted UB, Bauer J, Fuursted K, Lundgren J. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol. 1999;37:3901-3905.
34. Tortoli E, Brunello F, Cagni AE, Colombrita D, Dionisio D, Grisendi L, Manfrin V, Moroni M, Passerini Tosi C, Pinsi G, Scarparo C, Simonetti MT. Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol. 1998;14:219-224. (Pubitemid 28261355)
35. Trueba F, Fabre M, Saint-Blancard P. Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2. J Clin Microbiol. 2004;42:4403-4404. (Pubitemid 39296189)
36. Vergnaud M, Dauga C, Dompmartin A, Malbruny B, Bazin C, Grimont PA. Genital infection due to Mycobacterium genavense in a patient with AIDS. Clin Infect Dis. 1998;27:1531. (Pubitemid 29242435)
37. Wald A, Coyle MB, Carlson LC, Thompson RL, Hooton TM. Infection with a fastidious Mycobacterium resembling Mycobacterium simiae in seven patients with AIDS. Ann Intern Med. 1992;117:586-589.